|
End-of-day quote
Shenzhen S.E.
2026-08-18
|
5-day change | 1st Jan Change | ||
| 5.510 CNY | +9.98% |
|
+15.03% | +5.56% |
| Market Cap | 7.86B 1.17B 1.01B 947M 861M 1.62B 112B 1.65B 11.11B 4.35B 55.87B 4.38B 4.29B 186B | P/E 2024 |
18.2x | P/E 2025 | 29x |
|---|---|---|---|---|---|
| Enterprise Value | 6.37B 946M 816M 767M 698M 1.31B 90.53B 1.34B 9.01B 3.52B 45.28B 3.55B 3.48B 151B | EV / Sales 2024 |
0.62x | EV / Sales 2025 | 0.84x |
| Free-Float |
39.51% | Yield 2024 |
1.9% | Yield 2025 | 1.05% |
| 23-03-17 | China Monthly Antitrust Update - March 2023 | AQ |
| 1 day | +9.98% | ||
| 1 week | +15.03% | ||
| Current month | +20.31% | ||
| 1 month | +16.99% | ||
| 3 months | +12.91% | ||
| 6 months | +7.41% | ||
| Current year | +5.56% |
| 1 week | 4.78 |  | 5.51 |
| 1 month | 4.47 | | 5.51 |
| Current year | 4.09 | | 5.73 |
| 1 year | 4.09 | | 5.98 |
| 3 years | 3.72 | | 6.69 |
| 5 years | 3.72 | | 9.3 |
| 10 years | 3.72 | | 9.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong Gang Cai
CEO | Chief Executive Officer | 46 | 2025-01-20 |
Xin Li
DFI | Director of Finance/CFO | 46 | 2025-09-05 |
Dong Sheng Yan
IRC | Investor Relations Contact | 42 | 2024-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Kai Zhou
CHM | Chairman | 62 | 2025-01-20 |
Xin Hua Ao
BRD | Director/Board Member | 62 | 2018-07-17 |
Cheng Ren Huang
BRD | Director/Board Member | 62 | 2018-07-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.98% | +15.03% | -5.81% | +1.10% | 1.06B | |
| +3.60% | -0.50% | +74.80% | +127.97% | 1,055B | |
| +3.33% | +3.55% | +53.48% | +55.80% | 632B | |
| +3.43% | +4.42% | +25.27% | +72.59% | 442B | |
| +1.35% | -3.27% | +40.98% | +39.91% | 351B | |
| +1.75% | -0.98% | +26.20% | +39.73% | 290B | |
| +2.13% | -1.53% | +1.85% | +9.40% | 243B | |
| +1.41% | +1.94% | +43.45% | +61.18% | 227B | |
| +1.35% | -3.20% | -9.07% | -53.51% | 200B | |
| +3.25% | +7.80% | +21.18% | +87.50% | 172B | |
| Average | +1.93% | -0.08% | +27.23% | +44.17% | 361.36B | |
| Weighted average by Cap. | +0.43% | -1.87% | +43.72% | +68.74% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7.5B 1.11B 961M 903M 822M 1.55B 107B 1.57B 10.6B 4.15B 53.31B 4.18B 4.09B 178B | 7.07B 1.05B 906M 852M 775M 1.46B 101B 1.48B 10B 3.91B 50.27B 3.94B 3.86B 168B |
| Net income | 410M 60.86M 52.47M 49.34M 44.88M 84.42M 5.82B 85.92M 579M 227M 2.91B 228M 224M 9.71B | 260M 38.62M 33.3M 31.31M 28.48M 53.57M 3.69B 54.52M 368M 144M 1.85B 145M 142M 6.16B |
| Net Debt | -2.88B -427M -368M -346M -315M -592M -40.85B -603M -4.06B -1.59B -20.43B -1.6B -1.57B -68.15B | -1.49B -221M -191M -179M -163M -307M -21.18B -312M -2.11B -824M -10.59B -831M -813M -35.32B |
Employees
5,727
Sector
Pharmaceuticals
Calendar
Aug. 25
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-18 | CN¥5.510 | +9.98% | 82,403,093 |
| 26-08-17 | CN¥5.010 | -0.40% | 16,588,266 |
| 26-08-14 | CN¥5.030 | +1.21% | 26,294,714 |
| 26-08-13 | CN¥4.970 | +1.22% | 36,164,406 |
| 26-08-12 | CN¥4.910 | +1.66% | 18,697,009 |
- Stock Market
- Stocks
- 000597 Stock
Select your edition
All financial news and data tailored to specific country editions
